Impact Evaluation of a Targeted mHealth Intervention to Improve Uptake of Postpartum Contraception in Kenya

February 11, 2024 updated by: Jacaranda Health

The goal of this study is to explore approaches to improve postpartum contraceptive counseling, information, and uptake through a collaboration between the Harvard Chan School, Rutgers School of Public Health, Jacaranda Health, Jhpiego, and IPSOS, leveraging an existing mobile health platform for intervention delivery and Jacaranda's established partnership with the Kenyan Ministry of Health, county health offices and public maternity hospitals.

Jacaranda's PROMPTS mHealth platform has reached over two million pregnant women and new mothers, providing them with needed, tailored information about prenatal and postpartum health along with access to a mobile helpdesk to triage users' questions. Using a targeted human-centered-design process with early postpartum mothers, we developed targeted messaging around family planning and contraceptive method options, with the goal of integrating this new content into Jacaranda's PROMPTS platform. We will conduct a randomized controlled trial with pregnant women engaged with the PROMPTS platform to determine the impact of the intervention package on information and utilization of postpartum contraception. If proven effective, the results of this intervention will be integrated into Jacaranda's PROMPTS system at full scale.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

4190

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 15 and over,
  • Pregnant at 7-8 months gestation,
  • Consented to be enrolled in the PROMPTS text-messaging platform and who have provided informed consent to be part of this research study
  • Have access to a mobile phone

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
Group receiving enhanced package of postpartum family planning support
Based on a targeted human-centered-design process with pregnant and early postpartum mothers, the intervention consists of informative messages, counselling and reminders regarding postpartum family planning and birth spacing, leveraging an existing mobile health platform (PROMPTS) for intervention delivery and Jacaranda's established partnership with the Kenyan Ministry of Health, county health offices and public maternity hospitals method options. The intervention includes several features: activation of family planning discussions between pregnant and postpartum women and their health care providers, information provision, method selection support to help women choose their preferred method, and reminders to follow-up. The key feature is to help women make an informed plan about family planning in the prenatal or early postpartum period and follow through with this plan.
No Intervention: Control Group
Group receiving basic postpartum family planning information

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Use of postpartum family planning at 3 months
Time Frame: 3 months
The outcome is a binary variable, set to 1 if a participant reports using any modern family planning method (including Lactational Amenorrhea Method (LAM)) at the time of the survey. The modern methods considered will include sterilization (both male and female), implants, Intrauterine Device (IUD), injectables, oral contraceptives (pill), condoms (both male and female), diaphragm, foam/jelly, and LAM.
3 months
Use of postpartum family planning at 6 months
Time Frame: 6.5 months
The outcome is a binary variable, assigned a value of 1 if a participant reports using any modern family planning method, excluding LAM, at the time of the survey. The modern methods considered include sterilization (both male and female), implant, IUD, injectables, oral contraceptives (pill), condoms (both male and female), diaphragm, foam, and jelly.
6.5 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge of return to fertility
Time Frame: 3 months postpartum
The outcome is a binary variable, set to 1 if a participant is aware of the possibility of becoming pregnant after giving birth, even if she has not yet seen her period
3 months postpartum
Knowledge of safe birth spacing
Time Frame: 3 months postpartum
The outcome is a binary variable, set to 1 if a participant is aware of the minimum recommended delay between the delivery of a baby and the start of the next pregnancy (two years) to promote the health of both the mother and the child.
3 months postpartum
Knowledge of lactational amenorrhea (LAM) method
Time Frame: 3 months postpartum
This outcome is an index assessing knowledge of LAM as a method to avoid or delay pregnancy and consists of three items. The first item is a binary indicator, set to 1 if a participant has any familiarity with LAM. The second item is a binary variable, set to 1 if the participant, among those familiar with LAM, knows the recommended duration of LAM use post-delivery (up to 6 months after delivery). The third item is a binary variable, set to 1 if the participant, again among those familiar with LAM, is aware of the other two factors that can reduce the effectiveness of LAM (return of menstruation and the introduction of liquids/foods to the baby). Participants who are not familiar with LAM will automatically receive a score of 0 for the second and third items.
3 months postpartum
Intention to continue family planning method
Time Frame: 3 and 6.5 months postpartum
The outcome is a binary variable, assigned a value of 1 if a participant reports an intention to continue using the same family planning method that they were using at the time of the survey.
3 and 6.5 months postpartum
Intended duration of continued family planning method use
Time Frame: 3 and 6.5 months postpartum
Among participants who reported an intention to continue with their current family planning method, this outcome quantifies the number of months they plan to maintain its use, as indicated during the survey.
3 and 6.5 months postpartum
Desired pregnancy spacing of two years or more
Time Frame: 3 months postpartum

This outcome assesses participants' intentions regarding birth spacing following their recent pregnancy. The primary focus is to determine the proportion of participants planning a gap of at least two years before the onset of their next pregnancy. Participants' intentions are categorized into:

  • Less than 6 months
  • 6 months to less than 12 months
  • 1 year to less than 2 years
  • 2 years or more (main outcome of interest).
3 months postpartum
Short interpregnancy interval
Time Frame: 3 and 6.5 months postpartum
The outcome is a binary variable, assigned a value of 1 if a participant reports being pregnant at either of the two follow-up surveys conducted at 3 months or 6.5 months.
3 and 6.5 months postpartum
Method satisfaction
Time Frame: 3 and 6.5 months postpartum
This outcome is a discrete variable with values ranging from 1 (very unsatisfied) to 5 (very satisfied), assessing overall satisfaction with the current family planning method. It is evaluated only among participants who reported using a family planning method at the time of the survey.
3 and 6.5 months postpartum
Uptake of most effective family planning methods
Time Frame: 3 and 6.5 months postpartum
The outcome is a binary variable, set to 1 if a participant reports using any of the most effective family planning methods as classified by the US CDC at the time of the survey. The subset of the most effective methods includes: implant, IUD, sterilization, injectable, pill, patch, diaphragm, and ring.
3 and 6.5 months postpartum
Time to take-up of most effective methods
Time Frame: 0-6.5 months postpartum
This outcome is a continuous time variable, measured in weeks, representing the interval between delivery and first adoption of one of the most effective methods of family planning, as classified by the CDC. This outcome is calculated only for participants who reported using one or more of these most effective methods.
0-6.5 months postpartum
Discussion of FP at any prenatal visit
Time Frame: 3 months postpartum
The outcome is a binary variable, assigned a value of 1 if a participant reports having had a discussion about family planning with their antenatal care provider at any point during the prenatal period.
3 months postpartum
Discussion of FP at any postnatal visit
Time Frame: 3 months postpartum
The outcome is a binary variable, assigned a value of 1 if a participant reports having had a discussion about family planning with health staff at their postnatal care facility at any point during the postnatal period.
3 months postpartum
Reproductive empowerment: health care provider communication
Time Frame: 3 and 6.5 months postpartum
The outcome is an average score across 3 items measuring one aspect of reproductive empowerment: health care provider communication (participant reports being able to initiate conversations about using contraception with health care providers, ask health care provider questions about using contraception, and share opinions about using contraception with health care providers.)
3 and 6.5 months postpartum

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of helpdesk team in counselling on family planning
Time Frame: 6.5 months postpartum
This outcome is a discrete variable with values ranging from 1 (not helpful at all) to 5 (very helpful), indicating the quality of the helpdesk team's counseling on family planning methods. This outcome is measured only among participants who have interacted with a helpdesk agent.
6.5 months postpartum
Quality of message flow on method selection
Time Frame: 6.5 months postpartum
This outcome is an index with scores ranging from 3 to 15, based on three items with discrete scales measuring the quality of the message flow from the PROMPTS platform regarding method selection. Each item ranges from 1 (not helpful at all) to 5 (very helpful), assessing the usefulness of the messaging platform in: 1) educating about different family planning methods, 2) providing information related to any concerns or issues they had with family planning methods, and 3) assisting in the selection of a family planning method.
6.5 months postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anneka Wickramanayake, MPH, Jacaranda Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 2, 2024

Primary Completion (Estimated)

August 30, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

February 11, 2024

First Submitted That Met QC Criteria

February 11, 2024

First Posted (Actual)

February 20, 2024

Study Record Updates

Last Update Posted (Actual)

February 20, 2024

Last Update Submitted That Met QC Criteria

February 11, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • P1473-2023

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postpartum Family Planning

Clinical Trials on PROMPTS Enhanced Family Planning Counselling

Subscribe